Skip to main content
logo
Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.705
+0.145 (4.07%)
At close: Aug 17, 2026, 4:00 PM EDT
3.770
+0.065 (1.75%)
After-hours: Aug 17, 2026, 7:55 PM EDT

Zentalis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
266872161,0721,1493,808
Market Cap Growth
147.06%-59.52%-79.86%-6.72%-69.82%80.54%
Enterprise Value
129-153-1326017753,443
Last Close Price
3.561.353.0315.1520.1484.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.20---
PB Ratio
1.780.400.642.452.6510.45
P/TBV Ratio
1.860.400.642.472.6710.57

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.260.180.130.110.110.13
Net Debt / Equity Ratio
-0.95-0.95-0.97-1.00-0.90-0.81
Net Debt / EBITDA Ratio
0.911.471.761.771.731.42
Net Debt / FCF Ratio
1.071.651.922.102.351.84
Asset Turnover
--0.14---
Quick Ratio
4.646.737.136.967.727.74
Current Ratio
4.826.937.327.167.987.98
Return on Equity (ROE)
-66.75%-49.54%-42.83%-67.09%-59.39%-47.60%
Return on Assets (ROA)
-33.15%-24.48%-23.86%-28.53%-28.59%-31.67%
Return on Capital Employed (ROCE)
-84.60%-55.80%-49.60%-51.60%-47.10%-50.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-52.20%-156.79%-76.80%-27.25%-20.60%-4.17%
FCF Yield
-47.93%-143.28%-79.23%-19.44%-14.47%-4.21%
Buyback Yield / Dilution
0.23%-1.11%-8.67%-23.75%-23.82%-51.84%
SEC Filings: 10-K · 10-Q